Teleflex Incorporated (NYSE:TFX) Shares Acquired by Hsbc Holdings PLC

Hsbc Holdings PLC increased its position in shares of Teleflex Incorporated (NYSE:TFX) by 4.9% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 127,077 shares of the medical technology company’s stock after purchasing an additional 5,943 shares during the quarter. Hsbc Holdings PLC owned 0.27% of Teleflex worth $26,684,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the company. Riverview Trust Co purchased a new position in Teleflex during the 1st quarter worth approximately $31,000. Pineridge Advisors LLC acquired a new stake in shares of Teleflex in the fourth quarter worth $35,000. Versant Capital Management Inc raised its holdings in shares of Teleflex by 20,700.0% during the second quarter. Versant Capital Management Inc now owns 208 shares of the medical technology company’s stock worth $44,000 after purchasing an additional 207 shares during the last quarter. Blue Trust Inc. lifted its position in Teleflex by 78.2% during the second quarter. Blue Trust Inc. now owns 212 shares of the medical technology company’s stock valued at $48,000 after purchasing an additional 93 shares during the period. Finally, Quadrant Capital Group LLC boosted its holdings in Teleflex by 67.2% in the fourth quarter. Quadrant Capital Group LLC now owns 229 shares of the medical technology company’s stock valued at $57,000 after purchasing an additional 92 shares during the last quarter. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Insiders Place Their Bets

In other news, Director Stuart A. Randle sold 2,674 shares of the firm’s stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $238.93, for a total value of $638,898.82. Following the transaction, the director now owns 5,496 shares in the company, valued at $1,313,159.28. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 1.43% of the stock is owned by company insiders.

Analysts Set New Price Targets

TFX has been the topic of several analyst reports. Stephens increased their price target on Teleflex from $275.00 to $290.00 and gave the stock an “overweight” rating in a research report on Friday, August 2nd. Royal Bank of Canada lifted their price target on Teleflex from $235.00 to $260.00 and gave the company an “outperform” rating in a research report on Friday, August 2nd. Truist Financial boosted their price target on Teleflex from $240.00 to $247.00 and gave the company a “hold” rating in a report on Monday, August 5th. Finally, Piper Sandler raised shares of Teleflex from a “neutral” rating to an “overweight” rating and raised their price objective for the stock from $205.00 to $245.00 in a research note on Monday, July 1st. Three research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, Teleflex has an average rating of “Moderate Buy” and a consensus price target of $265.57.

Teleflex Trading Down 1.3 %

Shares of TFX stock opened at $242.50 on Friday. Teleflex Incorporated has a 1-year low of $177.63 and a 1-year high of $257.85. The company has a market cap of $11.42 billion, a price-to-earnings ratio of 38.92, a PEG ratio of 2.23 and a beta of 1.16. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.58 and a quick ratio of 1.44. The stock has a 50 day simple moving average of $235.35 and a 200-day simple moving average of $220.51.

Teleflex (NYSE:TFX) last posted its quarterly earnings data on Thursday, August 1st. The medical technology company reported $3.42 earnings per share for the quarter, topping analysts’ consensus estimates of $3.33 by $0.09. Teleflex had a net margin of 8.76% and a return on equity of 14.51%. The company had revenue of $749.70 million during the quarter, compared to analysts’ expectations of $762.98 million. During the same period in the prior year, the business posted $3.41 earnings per share. The firm’s revenue for the quarter was up .9% on a year-over-year basis. On average, equities research analysts expect that Teleflex Incorporated will post 13.97 EPS for the current fiscal year.

Teleflex Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, September 16th. Investors of record on Thursday, August 15th were issued a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 0.56%. The ex-dividend date was Thursday, August 15th. Teleflex’s payout ratio is 21.83%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.